Remarkable activity of novel agents bortezomib and thalidomi…
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Article, Chapter
Authors:
N.W. van de Donk
Publication:
Volume:107,
Issue:8,
Page(s):3415-3416
Published:
2006
We were unable to find direct full text links for this item.